Division for Cardiovascular Pharmacology Mid-Career Award honors mid-career independent investigators for contributions to cardiovascular science, including vascular pharmacology, recognizing scientific excellence.
Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates (Anticipated): September 2028 (Nomination deadline)
Funding Amounts: Division-sponsored achievement award
Summary: Recognizes mid-career independent investigators for contributions to cardiovascular science, including vascular pharmacology.
Key Information: Candidates must be primary members of ASPET’s Division for Cardiovascular Pharmacology.
The Division for Cardiovascular Pharmacology Mid-Career Award is an achievement award offered by the American Society for Pharmacology and Experimental Therapeutics (ASPET). Administered through its Division for Cardiovascular Pharmacology, the award recognizes and honors mid-career independent investigators working in any area of cardiovascular science, including vascular pharmacology.
The emphasis is on recognizing scientific contributions rather than supporting a specified research project. The award is presented biennially and is open to investigators across organizational settings, including academia, industry, and private or government institutes. It forms part of ASPET’s division-sponsored awards program, which recognizes excellence within each division’s scientific specialty.